KMS Medisurgi Ltd
₹ 126
0.00%
30 Mar
- close price
About
Incorporated in 2016, KMS Medisurgi Ltd manufactures and sells Surgical Equipment[1]
Key Points
- Market Cap ₹ 41.8 Cr.
- Current Price ₹ 126
- High / Low ₹ 132 / 120
- Stock P/E 70.8
- Book Value ₹ 25.2
- Dividend Yield 0.04 %
- ROCE 8.26 %
- ROE 5.59 %
- Face Value ₹ 10.0
Pros
- Debtor days have improved from 160 to 111 days.
Cons
- Stock is trading at 5.02 times its book value
- The company has delivered a poor sales growth of 6.16% over past five years.
- Company has a low return on equity of 6.74% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.62 | 8.89 | 8.41 | 7.90 | 7.32 | 9.86 | 10.34 | 7.51 | 10.32 | 11.03 | 13.88 | 13.94 | 12.74 | |
| 7.01 | 8.17 | 7.59 | 6.95 | 6.85 | 9.56 | 9.68 | 7.01 | 9.79 | 10.07 | 13.03 | 12.99 | 11.51 | |
| Operating Profit | 0.61 | 0.72 | 0.82 | 0.95 | 0.47 | 0.30 | 0.66 | 0.50 | 0.53 | 0.96 | 0.85 | 0.95 | 1.23 |
| OPM % | 8.01% | 8.10% | 9.75% | 12.03% | 6.42% | 3.04% | 6.38% | 6.66% | 5.14% | 8.70% | 6.12% | 6.81% | 9.65% |
| 0.05 | 0.04 | 0.06 | 0.17 | 0.35 | 0.42 | 0.00 | 0.10 | 0.05 | 0.02 | 0.03 | 0.03 | 0.05 | |
| Interest | 0.23 | 0.27 | 0.24 | 0.27 | 0.19 | 0.09 | 0.07 | 0.03 | 0.00 | 0.00 | 0.02 | 0.10 | 0.14 |
| Depreciation | 0.39 | 0.41 | 0.34 | 0.49 | 0.45 | 0.43 | 0.41 | 0.33 | 0.29 | 0.32 | 0.25 | 0.27 | 0.33 |
| Profit before tax | 0.04 | 0.08 | 0.30 | 0.36 | 0.18 | 0.20 | 0.18 | 0.24 | 0.29 | 0.66 | 0.61 | 0.61 | 0.81 |
| Tax % | 50.00% | 50.00% | 53.33% | 38.89% | 50.00% | 40.00% | 38.89% | 45.83% | 24.14% | 13.64% | 24.59% | 27.87% | |
| 0.03 | 0.03 | 0.14 | 0.21 | 0.10 | 0.12 | 0.11 | 0.12 | 0.22 | 0.57 | 0.45 | 0.44 | 0.59 | |
| EPS in Rs | 0.60 | 0.60 | 1.17 | 0.88 | 0.30 | 0.36 | 0.33 | 0.36 | 0.67 | 1.73 | 1.36 | 1.33 | 1.79 |
| Dividend Payout % | 0.00% | 0.00% | 25.71% | 5.71% | 16.50% | 13.75% | 15.00% | 13.75% | 7.50% | 2.89% | 3.67% | 3.75% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 6% |
| 3 Years: | 11% |
| TTM: | -12% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 31% |
| 5 Years: | 32% |
| 3 Years: | 26% |
| TTM: | 943% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 30% |
| 3 Years: | 22% |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 5% |
| 3 Years: | 7% |
| Last Year: | 6% |
Balance Sheet
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.50 | 0.50 | 1.20 | 2.40 | 3.30 | 3.30 | 3.30 | 3.30 | 3.30 | 3.30 | 3.30 | 3.30 | 3.30 |
| Reserves | 0.61 | 0.64 | 2.13 | 1.12 | 2.85 | 2.95 | 3.05 | 3.15 | 3.37 | 3.93 | 4.36 | 4.79 | 5.02 |
| 3.99 | 2.85 | 2.13 | 2.73 | 1.91 | 1.13 | 1.11 | 1.03 | 0.99 | 0.99 | 0.54 | 0.91 | 0.87 | |
| 1.91 | 3.21 | 2.60 | 2.36 | 2.14 | 3.15 | 1.64 | 1.86 | 2.17 | 1.51 | 2.65 | 1.34 | 2.97 | |
| Total Liabilities | 7.01 | 7.20 | 8.06 | 8.61 | 10.20 | 10.53 | 9.10 | 9.34 | 9.83 | 9.73 | 10.85 | 10.34 | 12.16 |
| 2.72 | 2.25 | 1.98 | 2.69 | 2.25 | 2.20 | 1.81 | 1.65 | 1.48 | 1.82 | 1.65 | 1.68 | 2.98 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 4.29 | 4.95 | 6.08 | 5.92 | 7.95 | 8.33 | 7.29 | 7.69 | 8.35 | 7.91 | 9.20 | 8.66 | 9.18 | |
| Total Assets | 7.01 | 7.20 | 8.06 | 8.61 | 10.20 | 10.53 | 9.10 | 9.34 | 9.83 | 9.73 | 10.85 | 10.34 | 12.16 |
Cash Flows
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.02 | 1.35 | -0.24 | 0.90 | -1.57 | 0.75 | -0.84 | 0.53 | -0.07 | 0.46 | 1.21 | 0.74 | |
| -1.82 | 0.05 | -0.03 | -1.10 | 0.11 | -0.31 | 0.01 | -0.10 | -0.12 | -0.66 | -0.51 | -0.96 | |
| 1.87 | -1.41 | 1.13 | 1.75 | 1.57 | -0.81 | -0.06 | -0.11 | -0.02 | -0.01 | -0.47 | 0.27 | |
| Net Cash Flow | 0.06 | -0.01 | 0.86 | 1.56 | 0.10 | -0.37 | -0.88 | 0.32 | -0.21 | -0.21 | 0.23 | 0.05 |
| Free Cash Flow | -1.80 | 1.40 | -0.31 | -0.29 | -1.58 | 0.36 | -0.86 | 0.36 | -0.19 | -0.20 | 1.09 | 0.44 |
| CFO/OP | 3% | 188% | -18% | 106% | -309% | 250% | -129% | 108% | 0% | 59% | 173% | 96% |
Ratios
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 143.22 | 128.10 | 163.19 | 185.73 | 233.36 | 186.94 | 194.15 | 305.22 | 231.31 | 216.42 | 152.00 | 111.02 |
| Inventory Days | 23.34 | 50.02 | 17.78 | 6.24 | 85.34 | 82.27 | 62.14 | 45.45 | 42.45 | 70.96 | 87.18 | |
| Days Payable | 110.10 | 155.51 | 141.02 | 139.76 | 134.58 | 134.09 | 70.42 | 100.27 | 58.60 | 85.22 | 41.86 | |
| Cash Conversion Cycle | 56.46 | 22.61 | 39.94 | 52.21 | 184.13 | 135.12 | 185.86 | 305.22 | 176.49 | 200.27 | 137.74 | 156.34 |
| Working Capital Days | 4.31 | 21.76 | 30.81 | 9.24 | 158.07 | 148.07 | 188.85 | 253.22 | 200.54 | 199.54 | 153.84 | 144.01 |
| ROCE % | 6.28% | 7.70% | 11.43% | 10.76% | 5.17% | 3.76% | 3.37% | 3.61% | 3.83% | 8.31% | 8.40% | 8.26% |
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Inventory of Raw Materials Rs. in Lakhs |
|
|||||||||
| Increase in Median Remuneration of Employees Percentage (%) |
||||||||||
| Number of Permanent Employees Number |
||||||||||
Requires Premium
Requires Premium
Documents
Announcements
-
Closure of Trading Window
1d - Trading window closed from 1 April 2026 until 48 hours after audited results for year/half-year ended 31 March 2026.
-
Non-Applicability Of Report On Corporate Governance Pursuant To Regulation 27 (2) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.
14 Jan - KMS Medisurgi: BSE SME listing exempts company from corporate governance report for quarter ended 31 Dec 2025.
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 14 Jan
-
Non-Applicability Of Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015
14 Nov 2025 - KMS Medisurgi (BSE SME) not required to disclose related party transactions for half-year ended Sep 30, 2025.
-
Board Meeting Outcome for Submission Of Unaudited Financial Results For The Half Year Ended September 30, 2025
14 Nov 2025 - Unaudited H1 results (30 Sep 2025): revenue Rs.661.66L, profit Rs.23.15L; limited review with qualifications
Business Overview:[1]
Company manufactures and undertakes jobwork of coating of various substrates films, cotton fabrics, taffeta silk fabrics with adhesive. It is in the business of marketing and distribution of Surgical Disposable, Haemostat, Medical Devices, Urology Equipment, Surgery equipment, Orthopaedic/ Physiotherapy equipment, Blood Banking Equipment, etc.